← SynDRA
CICLESONIDE
SynDRA canonical compound SYN0029326 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | Glucocorticoid receptor agonist |
|---|
| Indication | allergic rhinitis |
|---|
| Disease area | allergy |
|---|
All known targets
Mechanisms of action (all sources)
- NR3C1 AGONIST
- SERPINA6 BINDER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA3
- ESR1
- KCNH2
- PGR
- OPRK1
- NR1I2
- ADORA1
- NPY1R
- HTR2B
- HTR2C
- HTR3A
- MAOA
- MC3R
- MC4R
- MLNR
- OPRD1
- HTR1A
- OPRM1
- PDE3A
- PDE4D
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR2A
- HRH1
- HRH2
- ADORA2A
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
- CCKAR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Allergic Agents
- Glucocorticoids
- Hormones
ATC classes
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- ALVESCO
- Alvesco
- OMNARIS
- Omnaris
- ZETONNA
- Zetonna
- omnaris
- alvesco
- Ciclesonida
- BI54903
- RPR-251526
- RPR251526
- Alvesco 160
- Alvesco 80
- Aservo equihaler
- Omnair
- Osonase
- Osonide
- Alvesco HFA
- Ciclesonide [INN]
- Omnaris HFA
- RPR 251526
- Alvesco (TN)
- BTR-15
- BTR-15K
- BY-9010
- BYK-20426
- KS-1165
- Omnaris (TN)
- Omniair (TN)
- TBN-15
- B-9207-015
- Ciclesonide (JAN/USAN/INN)
- S59502J185
- Ciclesonide [USAN:INN]
- UNII-S59502J185
- NCGC00167484-01
- Zetonna (TN)
Reported adverse events
- Epistaxis
- Headache
- Nasopharyngitis
- Cataract
- Rhinitis
- Immunosuppression
Look up CICLESONIDE in the interactive SynDRA portal →